Product
Cysteamine
3 clinical trials
5 indications
Indication
CystinosisIndication
MelasmaIndication
Community-acquired PneumoniaIndication
InfluenzaIndication
COVID-19Clinical trial
Compare the Efficacy and Safety Profile of Cysteamine and Hydroquinone in Melasma as Topical ApplicationStatus: Completed, Estimated PCD: 2020-09-11
Clinical trial
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaStatus: Recruiting, Estimated PCD: 2026-02-01